Cancer immunotherapy with semi-allogeneic cells
AssigneeThe Board of Trustees of the University of Illinois
InventorEdward P. Cohen
Life of this patent
Estimating the term…
Abstract
The present invention relates to improved semi-allogeneic immunogenic cells which act to stimulate and induce an immunological response when administered to an individual. In particular, it relates to cells which express both allogeneic and syngeneic MHC determinants and which also express at least one antigen recognized by T lymphocytes. The invention is also directed to methods of inducing an immune response and methods of treating tumors by administering the semi-allogeneic immunogenic cells to an individual.
Claims15
A method of treating a tumor in an animal which comprises administering to said animal a tumor inhibiting effective amount of an antigen-presenting cell, wherein said antigen-presenting cell expresses at least one class I MHC or class II MHC determinant that is syngeneic to said animal and at least one class I or II MHC determinant that is allogeneic to said animal, wherein said antigen-presenting cell is selected from the group consisting of professional antigen-presenting cells and facultative antigen-presenting cells, and wherein said antigen-presenting cell is transfected with total genomic DNA isolated from the tumor cells of said animal.
A method of inhibiting tumor cell growth in an animal which comprises administering to said animal a tumor-inhibiting effective amount of an antigen-presenting cell, wherein said antigen presenting cell expresses at least one class I MHC or class II MHC determinant that is syngeneic to said animal and at least one class I or II MHC determinant that is allogeneic to said animal, wherein said antigen-presenting cell is selected from the group consisting of professional antigen-presenting cells and facultative antigen-presenting cells, and wherein said antigen-presenting cell is transfected with total genomic DNA isolated from the tumor cells of said animal.
Dependencies are inferred from the claim text.